Levine M R
Int Ophthalmol Clin. 1978 Fall;18(3):101-19.
An overview of the dry eye syndrome and its medical and surgical management has been presented. It is apparent that any single treatment is generally ineffective and that a combination of therapeutic modalities is required for success. The Experimental Slow Release Artificial Tear Insert (Ocusert) shows the most promise for a future solution.
本文已对干眼综合征及其药物和手术治疗进行了概述。显然，任何单一治疗通常都是无效的，成功需要多种治疗方式的联合应用。实验性缓释人工泪液插入剂（Ocusert）显示出最有希望成为未来的解决方案。
